Myelodysplastic Syndrome with Ph Negative Monosomy 7 Chromosome following Transient Bone Marrow Dysplasia during Imatinib Treatment for Chronic Myeloid Leukemia (Q83525115)

From Wikidata

Jump to navigation Jump to search

scientific article published on January 1, 2011

Language	Label	Description	Also known as
English	Myelodysplastic Syndrome with Ph Negative Monosomy 7 Chromosome following Transient Bone Marrow Dysplasia during Imatinib Treatment for Chronic Myeloid Leukemia	scientific article published on January 1, 2011

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21372464%20AND%20SRC:MED&resulttype=core&format=json

24 January 2020

Myelodysplastic syndrome with Ph negative monosomy 7 chromosome following transient bone marrow dysplasia during imatinib treatment for chronic myeloid leukemia (English)

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21372464%20AND%20SRC:MED&resulttype=core&format=json

24 January 2020

Myelodysplastic Syndrome with Ph Negative Monosomy 7 Chromosome following Transient Bone Marrow Dysplasia during Imatinib Treatment for Chronic Myeloid Leukemia (English)

1 reference

10.2169/INTERNALMEDICINE.50.4481

https://api.crossref.org/works/10.2169/INTERNALMEDICINE.50.4481

26 November 2024

myelodysplastic syndrome

1 reference

based on heuristic

inferred from title

chronic myeloid leukemia

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

3

object named as

Takashi Ushiki

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A21372464

26 November 2024

author name string

Kaori Karimata

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21372464%20AND%20SRC:MED&resulttype=core&format=json

24 January 2020

Masayoshi Masuko

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21372464%20AND%20SRC:MED&resulttype=core&format=json

24 January 2020

Takashi Kozakai

4

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21372464%20AND%20SRC:MED&resulttype=core&format=json

24 January 2020

Yasuhiko Shibasaki

5

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21372464%20AND%20SRC:MED&resulttype=core&format=json

24 January 2020

Toshio Yano

6

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21372464%20AND%20SRC:MED&resulttype=core&format=json

24 January 2020

Takashi Abe

7

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21372464%20AND%20SRC:MED&resulttype=core&format=json

24 January 2020

Masato Moriyama

8

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21372464%20AND%20SRC:MED&resulttype=core&format=json

24 January 2020

Ken Toba

9

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21372464%20AND%20SRC:MED&resulttype=core&format=json

24 January 2020

Tatsuo Furukawa

10

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21372464%20AND%20SRC:MED&resulttype=core&format=json

24 January 2020

Yoshifusa Aizawa

11

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21372464%20AND%20SRC:MED&resulttype=core&format=json

24 January 2020

language of work or name

1 reference

National Center for Biotechnology Information

PubMed publication ID

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=21372464

26 November 2024

publication date

1 March 2011

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21372464%20AND%20SRC:MED&resulttype=core&format=json

24 January 2020

2011

1 reference

National Center for Biotechnology Information

PubMed publication ID

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=21372464

26 November 2024

Internal Medicine

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21372464%20AND%20SRC:MED&resulttype=core&format=json

24 January 2020

50

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21372464%20AND%20SRC:MED&resulttype=core&format=json

24 January 2020

5

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21372464%20AND%20SRC:MED&resulttype=core&format=json

24 January 2020

481-485

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21372464%20AND%20SRC:MED&resulttype=core&format=json

24 January 2020

Tyrosine kinase activity and transformation potency of bcr-abl oncogene products.

2

1 reference

10.2169/INTERNALMEDICINE.50.4481

https://api.crossref.org/works/10.2169/INTERNALMEDICINE.50.4481

26 November 2024

Efficacy and safety of a specific inhibitor of the BCR-ABL tyrosine kinase in chronic myeloid leukemia

3

1 reference

10.2169/INTERNALMEDICINE.50.4481

https://api.crossref.org/works/10.2169/INTERNALMEDICINE.50.4481

26 November 2024

Frequency of major molecular responses to imatinib or interferon alfa plus cytarabine in newly diagnosed chronic myeloid leukemia

4

1 reference

10.2169/INTERNALMEDICINE.50.4481

https://api.crossref.org/works/10.2169/INTERNALMEDICINE.50.4481

26 November 2024

Dasatinib versus imatinib in newly diagnosed chronic-phase chronic myeloid leukemia

5

1 reference

10.2169/INTERNALMEDICINE.50.4481

https://api.crossref.org/works/10.2169/INTERNALMEDICINE.50.4481

26 November 2024

Evolving concepts in the management of chronic myeloid leukemia: recommendations from an expert panel on behalf of the European LeukemiaNet

6

1 reference

10.2169/INTERNALMEDICINE.50.4481

https://api.crossref.org/works/10.2169/INTERNALMEDICINE.50.4481

26 November 2024

Demonstration of Philadelphia chromosome negative abnormal clones in patients with chronic myelogenous leukemia during major cytogenetic responses induced by imatinib mesylate.

7

1 reference

10.2169/INTERNALMEDICINE.50.4481

https://api.crossref.org/works/10.2169/INTERNALMEDICINE.50.4481

26 November 2024

Emergence of clonal cytogenetic abnormalities in Ph- cells in some CML patients in cytogenetic remission to imatinib but restoration of polyclonal hematopoiesis in the majority

8

1 reference

10.2169/INTERNALMEDICINE.50.4481

https://api.crossref.org/works/10.2169/INTERNALMEDICINE.50.4481

26 November 2024

Chromosomal abnormalities in Philadelphia chromosome-negative metaphases appearing during imatinib mesylate therapy in patients with Philadelphia chromosome-positive chronic myelogenous leukemia in chronic phase

9

1 reference

10.2169/INTERNALMEDICINE.50.4481

https://api.crossref.org/works/10.2169/INTERNALMEDICINE.50.4481

26 November 2024

Report of 34 patients with clonal chromosomal abnormalities in Philadelphia-negative cells during imatinib treatment of Philadelphia-positive chronic myeloid leukemia.

10

1 reference

10.2169/INTERNALMEDICINE.50.4481

https://api.crossref.org/works/10.2169/INTERNALMEDICINE.50.4481

26 November 2024

Characterization of Ph-negative abnormal clones emerging during imatinib therapy

11

1 reference

10.2169/INTERNALMEDICINE.50.4481

https://api.crossref.org/works/10.2169/INTERNALMEDICINE.50.4481

26 November 2024

Philadelphia-negative clonal hematopoiesis following imatinib therapy in patients with chronic myeloid leukemia: a report of nine cases and analysis of predictive factors.

12

1 reference

10.2169/INTERNALMEDICINE.50.4481

https://api.crossref.org/works/10.2169/INTERNALMEDICINE.50.4481

26 November 2024

The prognosis for patients with chronic myeloid leukemia who have clonal cytogenetic abnormalities in philadelphia chromosome-negative cells

13

1 reference

10.2169/INTERNALMEDICINE.50.4481

https://api.crossref.org/works/10.2169/INTERNALMEDICINE.50.4481

26 November 2024

Chromosomal abnormalities in Philadelphia chromosome negative metaphases appearing during imatinib mesylate therapy in patients with newly diagnosed chronic myeloid leukemia in chronic phase.

14

1 reference

10.2169/INTERNALMEDICINE.50.4481

https://api.crossref.org/works/10.2169/INTERNALMEDICINE.50.4481

26 November 2024

Myelodysplastic syndromes and acute leukemia developing after imatinib mesylate therapy for chronic myeloid leukemia

15

1 reference

10.2169/INTERNALMEDICINE.50.4481

https://api.crossref.org/works/10.2169/INTERNALMEDICINE.50.4481

26 November 2024

Monosomy 7 with severe myelodysplasia developing during imatinib treatment of Philadelphia-positive chronic myeloid leukemia: Two cases with a different outcome

16

1 reference

10.2169/INTERNALMEDICINE.50.4481

https://api.crossref.org/works/10.2169/INTERNALMEDICINE.50.4481

26 November 2024

Hyperleukocytotic secondary acute myeloid leukemia (AML) with sole monosomy 7 as sequela of Philadelphia-chromosome positive chronic myeloid leukemia (CML).

17

1 reference

10.2169/INTERNALMEDICINE.50.4481

https://api.crossref.org/works/10.2169/INTERNALMEDICINE.50.4481

26 November 2024

Chronic myeloid leukemia: an update of concepts and management recommendations of European LeukemiaNet

18

1 reference

10.2169/INTERNALMEDICINE.50.4481

https://api.crossref.org/works/10.2169/INTERNALMEDICINE.50.4481

26 November 2024

Myelodysplastic syndrome appearing during imatinib mesylate therapy in a patient with GIST.

19

1 reference

10.2169/INTERNALMEDICINE.50.4481

https://api.crossref.org/works/10.2169/INTERNALMEDICINE.50.4481

26 November 2024

Monosomy 7 in t(9;22)-negative cells during nilotinib therapy in an imatinib-resistant chronic myeloid leukemia case

21

1 reference

10.2169/INTERNALMEDICINE.50.4481

https://api.crossref.org/works/10.2169/INTERNALMEDICINE.50.4481

26 November 2024

Emergence of abnormal clone with monsomy 7 in Philadelphia negative cells of CML patients treated with tyrosine kinase inhibitors

22

1 reference

10.2169/INTERNALMEDICINE.50.4481

https://api.crossref.org/works/10.2169/INTERNALMEDICINE.50.4481

26 November 2024

Genetic analysis of dasatinib-treated chronic myeloid leukemia rapidly developing into acute myeloid leukemia with monosomy 7 in Philadelphia-negative cells

23

1 reference

10.2169/INTERNALMEDICINE.50.4481

https://api.crossref.org/works/10.2169/INTERNALMEDICINE.50.4481

26 November 2024

Identifiers

10.2169/INTERNALMEDICINE.50.4481

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21372464%20AND%20SRC:MED&resulttype=core&format=json

24 January 2020

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21372464%20AND%20SRC:MED&resulttype=core&format=json

24 January 2020

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q83525115&oldid=2279798906"